Evidence map›Paper›PMID 20890303›Full record

ArticleOncogene2011

Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium.

J Suo, S J Snider, G B Mills, C J Creighton, A C Chen, R Schiff, R E Lloyd, E C Chang

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

J SuoDepartment of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
S J Snider
G B Mills
C J Creighton
A C Chen
R Schiff
R E Lloyd
E C Chang
Baylor College of Medicine · USThe University of Texas MD Anderson Cancer Center · US

Funding

TUMOR SUPPRESSOR GENES IN BREAST CANCER DEVELOPMENTP50CA058183 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT · PI OSBORNE, C KENT · 1992 to 2012
$30.9M
Translation Regulation by Enterovirus ProteinaseR01AI050237 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI LLOYD, RICHARD E · 2002 to 2022
$6.9M
REGULATION OF GENETIC STABILITY BY THE INT6 FAMILYR01CA090464 · NCI · NEW YORK UNIVERSITY · PI CHANG, ERIC C · 2002 to 2011
$2.5M
MECHANISMS OF TRANSLATION CONTROL DURING APOPTOSISR01GM059803 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI LLOYD, RICHARD E · 1999 to 2007
$2.2M
Selective control of multiple Ras signaling activitiesR01CA107187 · NCI · BAYLOR COLLEGE OF MEDICINE · PI CHANG, ERIC C · 2005 to 2008
$989k
Translation Regulation by Enterovirus ProteinaseR56AI050237 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI LLOYD, RICHARD E · 2007 to 2007
$384k
NCI NIH HHS CA107187NCI NIH HHS CA90464NCI NIH HHS P50 CA058183NCI NIH HHS P50CA058183NCI NIH HHS P50CA58183NCI NIH HHS R01 CA090464NCI NIH HHS R01 CA107187NIAID NIH HHS AI50237NIAID NIH HHS R01 AI050237NIAID NIH HHS R56 AI050237NIGMS NIH HHS GM59803NIGMS NIH HHS R01 GM059803
6 · The paper itself

Abstract

INT6/EIF3E has been implicated in breast tumorigenesis, but its functional activities remain poorly defined. We found that, repressing INT6 expression induced transformed properties in normal human mammary epithelium (MCF10A); in contrast, Int6 silencing induced apoptosis in HeLa cells. As in fission yeast, Int6 in human cells was required for assembly of active proteasomes. A reverse-phase protein array screen identified SRC3/AIB1 as one oncoprotein the level and stability of which increased when Int6 was silenced in MCF10A cells. Our data further show that Int6 binds SRC3 and its ubiquitin ligase Fbw7, thus perhaps mediating the interaction between SRC3-Fbw7 and proteasomes. Consistent with this, Int6 silencing did not increase SRC3 levels in HeLa cells, which have low Fbw7 levels. It is surprising that, however, polyubiquitylated proteins do not accumulate or may even decrease in Int6-silenced cells that contain defective proteasomes. Considering that decreased ubiquitin might explain this observation and that Int6 might control ubiquitin levels in its role as a subunit of eIF3 (eukaryote translation initiation factor 3), we found that silencing Int6 reduced monoubiquitin protein levels, which correlated with a shift of ubiquitin mRNAs from larger polysomes to non-translating ribosomes. In contrast, levels of many housekeeping proteins did not change. This apparent reduction in the translation of ubiquitin genes correlated with a modest reduction in protein synthesis rate and formation of large polysomes. To further determine whether Int6 can selectively control translation, we analyzed translation of different 5'-untranslated region reporters and found that indeed, loss of Int6 had differential effects on these reporters. Together the data suggest that Int6 depletion blocks ubiquitin-dependent proteolysis by decreasing both ubiquitin levels and the assembly of functional proteasome machinery, leading to accumulation of oncoproteins, such as SRC3 that can transform mammary epithelium. Our data also raise the possibility that Int6 can further fine-tune protein levels by selectively controlling translation of specific mRNAs.

Indexed as

Protein BiosynthesisCell Cycle ProteinsCell Line, TumorEukaryotic Initiation Factor-3F-Box ProteinsF-Box-WD Repeat-Containing Protein 7Gene SilencingHumansMammary Glands, HumanNuclear Receptor Coactivator 3PolyribosomesProteasome Endopeptidase ComplexProtein BindingRibosomesUbiquitin-Protein LigasesCell Cycle ProteinsEukaryotic Initiation Factor-3F-Box ProteinsF-Box-WD Repeat-Containing Protein 7FBXW7 protein, humanNCOA3 protein, humanNuclear Receptor Coactivator 3Proteasome Endopeptidase ComplexUbiquitin-Protein Ligases

Identifiers

PMID20890303
PMCPMC3017639
OpenAlexW1994649465

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.